ArticleContemporary clinical trials communications2023

INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion.

Ethan Weinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.